Systemic inflammation and comorbidity in COPD: a result of 'overspill' of inflammatory mediators from the lungs? Review of the evidence.
about
Inflammatory effects of woodsmoke exposure among wildland firefighters working at prescribed burns at the Savannah River Site, SCStatins versus placebo for people with chronic obstructive pulmonary disease (COPD)COPD and osteoporosis: links, risks, and treatment challengesMuscle dysfunction in chronic obstructive pulmonary disease: update on causes and biological findingsExcess costs of comorbidities in chronic obstructive pulmonary disease: a systematic reviewPredictive medicine: outcomes, challenges and opportunities in the Synergy-COPD projectBiomarkers in chronic obstructive pulmonary disease: confusing or useful?Pulmonary-intestinal cross-talk in mucosal inflammatory diseaseOsteoporosis Associated with Chronic Obstructive Pulmonary DiseaseChronic obstructive pulmonary disease patients have greater systemic responsiveness to ex vivo stimulation with swine dust extract and its components versus healthy volunteersDexamethasone blocks the systemic inflammation of alveolar hypoxia at several sites in the inflammatory cascadeImproved air quality and attenuated lung function decline: modification by obesity in the SAPALDIA cohortAlveolar macrophages initiate the systemic microvascular inflammatory response to alveolar hypoxiaCross-sectional and prospective study of the association between lung function and prediabetesAbility of Reduced Lung Function to Predict Development of Atrial Fibrillation in Persons Aged 45 to 84 Years (from the Multi-Ethnic Study of Atherosclerosis-Lung Study)Cigarette Smoke Disturbs the Survival of CD8+ Tc/Tregs Partially through Muscarinic Receptors-Dependent Mechanisms in Chronic Obstructive Pulmonary DiseaseAir pollution and subclinical airway inflammation in the SALIA cohort studyIs periodontitis a comorbidity of COPD or can associations be explained by shared risk factors/behaviors?Adipokines NUCB2/nesfatin-1 and visfatin as novel inflammatory factors in chronic obstructive pulmonary disease.Differential expression of C-reactive protein and serum amyloid A in different cell types in the lung tissue of chronic obstructive pulmonary disease patientsInflammatory cytokine response to exercise in alpha-1-antitrypsin deficient COPD patients 'on' or 'off' augmentation therapy.Distinguishing adult-onset asthma from COPD: a review and a new approach.Systemic and pulmonary inflammation is independent of skeletal muscle changes in patients with chronic obstructive pulmonary disease.A pilot examination of the genome-wide DNA methylation signatures of subjects entering and exiting short-term alcohol dependence treatment programs.Impaired CTLA-4 responses in COPD are associated with systemic inflammationAnxiety and depression-Important psychological comorbidities of COPD.Update on the potential role of statins in chronic obstructive pulmonary disease and its co-morbidities.Hypoxemia in patients with COPD: cause, effects, and disease progressionStudies of the pharmacology of 17α-ethynyl-androst-5-ene-3β,7β,17β-triol, a synthetic anti-inflammatory androstene.Plasma YKL-40 and all-cause mortality in patients with chronic obstructive pulmonary disease.Fracture prevention in COPD patients; a clinical 5-step approachBufei Jianpi granules improve skeletal muscle and mitochondrial dysfunction in rats with chronic obstructive pulmonary diseaseSafety of indacaterol in the treatment of patients with COPD.Neutrophil-to-lymphocyte ratio, calprotectin and YKL-40 in patients with chronic obstructive pulmonary disease: correlations and 5-year mortality - a cohort studyInhaled Pharmacotherapy and Stroke Risk in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Population Based Study Using Two-Stage Approach.Leukocyte Mitochondrial DNA Copy Number Is Associated with Chronic Obstructive Pulmonary DiseaseSystemic signs of neutrophil mobilization during clinically stable periods and during exacerbations in smokers with obstructive pulmonary disease.Club Cell-16 and RelB as Novel Determinants of Arterial Stiffness in Exacerbating COPD Patients.Heart rate variability in association with frequent use of household sprays and scented products in SAPALDIA.Reduced Stroke Risk After Parathyroidectomy in End-Stage Renal Disease: A 13-Year Population-Based Cohort Study.
P2860
Q23909994-10C7AD81-8350-416D-B0DD-22CFB1F8CF4BQ24188188-100C9011-D0DB-4524-989F-B07BBCA80BB4Q26751371-41E3C024-6C5B-4AB1-8029-3DE90F4BF987Q26775701-10EB2AEC-8B36-4D19-9EA5-CE792E32F142Q26828976-72FD820F-879D-4762-9788-BDCFF3D52741Q27014689-9B49DF2A-1F10-4F91-9011-F4AA74DCCDB2Q27690280-0006B215-0D29-4C5C-B551-541889F84ABBQ27693862-03D94F53-54B4-4E6F-9FF7-F6176EB62F34Q28070018-095ECFD9-8F6A-490E-AC9B-E0D72501E635Q28384754-B395B088-6DFF-4A8A-9BD6-9C6EA0F0D088Q28386843-46726BEB-350D-47A9-901B-799C8333D461Q28388172-54072AF4-87D1-4751-A52F-322E91B015ABQ28391139-2C522F17-C893-4860-BDD9-B6F16CBA165DQ28395087-02F43197-83B3-4B22-A8B8-35C05853DA10Q28395242-DA4AC33B-BBD1-4DA4-9E0C-CF651143945EQ28552804-B8DABF26-7645-4D3F-B762-B6EDF1422287Q28658287-7F3AD8F8-812B-493F-A7C3-8691034BA9EBQ33649907-E8AC6F43-3BE3-44E8-9B99-5CD03CEF651DQ33660762-DB0AECAF-F600-4D47-9D47-EA43319E682DQ33732176-C00D58ED-2B66-4CB9-8F41-5F4935644FB0Q33880491-CDF50DFE-9E97-4DD1-A415-5B71137CC71DQ34198033-52414F1C-85B9-42DA-8F7B-30FCF6CFD0E0Q34211965-A2E4F383-799D-467F-AA17-11665A455E92Q34212648-BE7C86AC-10A0-49AE-B9D6-48E86249436CQ34455601-1EBE3475-65C0-4F27-A8D2-720EA71F57D2Q34628577-093839B3-BCC5-4E14-9D94-27F1E552442BQ34656726-6BCD08D4-7400-49CC-B5BB-196AF373E9FCQ35023212-54391C43-2D3B-4184-A74A-603E4F0EBA9EQ35040708-5581A2AE-E554-4056-8F89-09D456363290Q35077055-C44841A4-463A-4EFD-9C19-B75B14386004Q35158568-5193CCAC-5994-412A-86BE-CBF78163B4C3Q35228335-F0359C01-F5AF-4E0E-86CA-DCA772BF191EQ35268351-7A27560D-4032-4750-9772-A601463CE1D9Q35530179-0B5FCE76-BA75-4E59-96F4-9FE9DA135A66Q35687073-C75E955E-5298-4D71-8B80-E5FA10A8E693Q35783477-801F12E1-8DC5-4BAE-B66A-642B646E63F5Q35825949-55DE7394-3CD9-4DDE-A11F-36551D98F740Q35935690-1CEFE740-B530-42BC-B559-004C0A839677Q36115404-4B4C6151-840E-419D-8A56-F1A79CCC4393Q36194208-F1BD07E2-ADCE-4DA2-B7FC-AB7AFFBA44B8
P2860
Systemic inflammation and comorbidity in COPD: a result of 'overspill' of inflammatory mediators from the lungs? Review of the evidence.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 July 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Systemic inflammation and como ...... lungs? Review of the evidence.
@en
Systemic inflammation and como ...... lungs? Review of the evidence.
@nl
type
label
Systemic inflammation and como ...... lungs? Review of the evidence.
@en
Systemic inflammation and como ...... lungs? Review of the evidence.
@nl
prefLabel
Systemic inflammation and como ...... lungs? Review of the evidence.
@en
Systemic inflammation and como ...... lungs? Review of the evidence.
@nl
P356
P1433
P1476
Systemic inflammation and como ...... lungs? Review of the evidence.
@en
P2093
Nicola J Sinden
Robert A Stockley
P304
P356
10.1136/THX.2009.130260
P407
P577
2010-07-13T00:00:00Z